RPRX icon

Royalty Pharma

212 hedge funds and large institutions have $10.8B invested in Royalty Pharma in 2021 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 85 increasing their positions, 56 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more funds holding

Funds holding:

4.44% more ownership

Funds ownership: 59.3%63.74% (+4.4%)

2% more call options, than puts

Call options by funds: $46.5M | Put options by funds: $45.7M

5% less capital invested

Capital invested by funds: $11.4B → $10.8B (-$608M)

Holders
212
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
11
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$46.5M
Puts
$45.7M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
76
$4.74M
77
$4.71M
78
$4.63M
79
$4.62M
80
$4.57M
81
$4.46M
82
$4.38M
83
$4.36M
84
$4.36M
85
$4.23M
86
$4.21M
87
$4.13M
88
$4.09M
89
$4.06M
90
$4M
91
$3.52M
92
$3.49M
93
$3.31M
94
$3.15M
95
$2.96M
96
$2.91M
97
$2.76M
98
$2.68M
99
$2.56M
100
$2.55M